GDF-15 Blood Test — Mitochondrial & Cellular Stress
GDF-15 (Growth Differentiation Factor 15) is a blood biomarker that can become substantially elevated in mitochondrial disease and other states of cellular stress. It provides a different perspective from lactate/pyruvate, CK and carnitine testing and may be useful when symptoms or initial laboratory findings justify a deeper mitochondrial evaluation.
An elevated GDF-15 does not by itself diagnose mitochondrial disease or determine a specific treatment. The result is interpreted with symptoms, other laboratory findings and potential non-mitochondrial causes, and may help determine whether additional metabolic or genetic evaluation is appropriate.
Description
GDF-15 provides a different window into mitochondrial health. Rather than measuring a fuel, nutrient or metabolic intermediate, GDF-15 reflects a cellular stress response that can become significantly activated in mitochondrial disease.
The test can add evidence when mitochondrial dysfunction is strongly suspected, particularly when symptoms involve high-energy tissues such as muscle, brain, heart or vision. However, GDF-15 is not specific to mitochondria and should always be interpreted in clinical context.
What Is GDF-15?
GDF-15 stands for Growth Differentiation Factor 15. It is a circulating protein whose production can increase when cells are exposed to significant physiological stress.
Mitochondrial dysfunction can activate cellular stress-response pathways that increase GDF-15. This has made GDF-15 an increasingly useful biochemical marker in the investigation of mitochondrial disorders.
↓
CELLULAR STRESS RESPONSE
↓
INCREASED GDF-15
↓
MEASURABLE IN BLOOD
Why Add GDF-15 to Mitochondrial Testing?
The Core Mitochondrial Function & Cellular Energy Panel examines lactate/pyruvate, CK and free/total carnitine. GDF-15 answers a different question.
Metabolic Function
Lactate + Pyruvate examine oxidative/redox metabolism, CK looks for muscle involvement, and carnitine evaluates a potentially correctable component of fatty-acid metabolism.
Cellular Stress
GDF-15 asks whether a significant cellular stress response is present that may add evidence supporting mitochondrial involvement.
Who Might Consider GDF-15 Testing?
GDF-15 is generally more appropriate as an additional mitochondrial biomarker than as a routine wellness test.
Unexplained poor stamina, disproportionate fatigue with activity or prolonged recovery.
Weakness, muscle fatigue or other findings suggesting possible mitochondrial muscle involvement.
Neurological or cognitive findings occurring as part of a broader suspected mitochondrial pattern.
Selected retinal, optic, auditory or multisystem presentations may raise mitochondrial suspicion.
Abnormal metabolic testing may provide a reason to add a different mitochondrial biomarker.
Symptoms affecting several high-energy tissues may justify a more extensive mitochondrial evaluation.
What Does an Elevated GDF-15 Mean?
An elevated GDF-15 indicates increased cellular stress—but does not identify the cause by itself.
When the clinical presentation and other biochemical findings are compatible with mitochondrial disease, an elevated GDF-15 can provide additional supporting evidence and may justify further investigation.
GDF-15 ELEVATED
↓
CONFIRM THE CLINICAL CONTEXT
↓
LOOK FOR MITOCHONDRIAL + NON-MITOCHONDRIAL CAUSES
↓
ADD TARGETED TESTING WHEN WARRANTED
↓
TREAT THE IDENTIFIED CONTRIBUTORS
High GDF-15 Does Not Always Mean Mitochondrial Disease
This is the most important limitation of the test. GDF-15 is a cellular stress biomarker rather than a mitochondrial-specific protein.
Levels can be influenced by other conditions, so an abnormal result must be interpreted alongside the patient's health history and other laboratory findings.
Cardiac and vascular stress can increase GDF-15.
Diabetes and other metabolic stress states can influence GDF-15.
Cancer and other significant systemic illnesses can increase GDF-15.
Does a Normal GDF-15 Rule Out Mitochondrial Dysfunction?
No. Mitochondrial disorders vary considerably in the tissues affected, severity, genetics and biochemical expression.
A normal GDF-15 reduces one source of supporting evidence but does not independently exclude mitochondrial dysfunction or primary mitochondrial disease.
Does an Elevated GDF-15 Determine Treatment?
No. GDF-15 is not currently a treatment-selection test. An elevated result does not automatically indicate carnitine, CoQ10, creatine, NAD-related treatment, SS-31, MOTS-c or another mitochondrial therapy.
Instead, the result can help establish that significant cellular stress is present and strengthen the rationale for identifying the underlying cause.
Evaluate metabolic, nutritional, cardiovascular, medication, systemic and other potential contributors according to the clinical presentation.
Combine GDF-15 with metabolic testing rather than interpreting it as an isolated mitochondrial diagnosis.
Acylcarnitines, organic acids and more specialized metabolic or genetic evaluation may be appropriate in selected patients.
Treatment should address the identified abnormalities and clinical condition rather than attempting to treat the GDF-15 number itself.
When Should GDF-15 Be Retested?
GDF-15 does not need to become a routine serial “mitochondrial health” measurement. Retesting is most useful when the initial result was meaningfully elevated and repeating it can answer a specific clinical question.
An elevated pretreatment value establishes an objective biochemical baseline.
Treat or investigate the condition believed to be contributing to cellular stress.
Repeat testing may be reasonable when a change would meaningfully contribute to assessment of the patient's biochemical response.
What Testing May Come Next?
GDF-15 is most useful when it becomes part of a structured testing strategy rather than an isolated laboratory result.
Core Blood Panel
Lactate/pyruvate, CK and free/total carnitine provide complementary information about energy metabolism, muscle and carnitine status.
View Core Panel →Acylcarnitines
A deeper assessment of fatty-acid oxidation and carnitine-linked mitochondrial metabolism.
View Acylcarnitines →Organic Acids
Provides a broader assessment of metabolic intermediates involving cellular energy and related biochemical pathways.
View Organic Acids →Build the Mitochondrial Picture Step by Step
CORE METABOLIC TESTING
Lactate/Pyruvate • CK • Free & Total Carnitine
ADDITIONAL EVIDENCE OF CELLULAR STRESS
GDF-15
EXPAND WHEN INDICATED
Acylcarnitines • Organic Acids
METABOLIC / GENETIC EVALUATION WHEN WARRANTED
What GDF-15 Does—and Does Not—Tell You
What It Can Do
- Add evidence of significant cellular stress
- Support mitochondrial investigation in the appropriate clinical setting
- Complement traditional metabolic biomarkers
- Help determine whether deeper testing is warranted
- Provide a baseline when significantly elevated
What It Cannot Do
- Diagnose mitochondrial disease by itself
- Identify the cause of cellular stress by itself
- Exclude mitochondrial dysfunction when normal
- Determine which mitochondrial therapy will work
- Predict response to a mitochondrial peptide
Frequently Asked Questions About GDF-15 Testing
What does GDF-15 measure?
GDF-15 measures Growth Differentiation Factor 15, a circulating protein that can increase as part of the body's cellular stress response.
Does high GDF-15 mean I have mitochondrial disease?
No. An elevated result can support mitochondrial investigation in the appropriate clinical setting, but GDF-15 can also increase with several non-mitochondrial conditions.
Can GDF-15 be normal in mitochondrial disease?
Yes. A normal result does not independently exclude mitochondrial disease, particularly because mitochondrial disorders differ substantially in their genetics, tissues affected and biochemical expression.
Is GDF-15 better than lactate?
They measure different biological processes. Lactate provides information about energy metabolism, while GDF-15 reflects a cellular stress response. The tests can therefore be complementary rather than interchangeable.
Does an elevated GDF-15 mean I should take mitochondrial supplements?
No. The result should first be interpreted in the context of the patient's symptoms, other laboratory findings and potential causes of cellular stress.
Does GDF-15 predict whether SS-31 will work?
No. GDF-15 should not currently be considered a general predictive biomarker for response to SS-31 or another mitochondrial therapy.
Should GDF-15 be repeated after treatment?
Retesting may be useful when the initial value was significantly elevated and a repeat measurement would help answer a specific clinical question. Routine serial testing of a normal result is generally less informative.
GDF-15 Adds Another Piece to the Mitochondrial Picture
GDF-15 can provide additional evidence of mitochondrial-associated cellular stress, but the strongest evaluation combines biomarkers with symptoms, metabolic testing and appropriate investigation of other possible causes.